Compare LSBK & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSBK | ADVB |
|---|---|---|
| Founded | 1891 | 2014 |
| Country | United States | United States |
| Employees | N/A | 31 |
| Industry | Savings Institutions | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.0M | 109.2M |
| IPO Year | 2025 | N/A |
| Metric | LSBK | ADVB |
|---|---|---|
| Price | $14.62 | $4.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.9K | ★ 174.9K |
| Earning Date | 04-28-2026 | 02-13-2026 |
| Dividend Yield | ★ 2.47% | N/A |
| EPS Growth | ★ 49.23 | N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.05 | ★ $1.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.50 | $0.19 |
| 52 Week High | $16.40 | $5.82 |
| Indicator | LSBK | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 26.77 | 57.88 |
| Support Level | $14.59 | $0.36 |
| Resistance Level | $15.15 | $5.75 |
| Average True Range (ATR) | 0.17 | 0.48 |
| MACD | -0.12 | -0.20 |
| Stochastic Oscillator | 9.59 | 13.02 |
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.